Epirubicin 50

Epirubicin 50 mg Injection
Epirubicin 50 mg Injection is an anthracycline antineoplastic antibiotic widely used in combination chemotherapy regimens for the treatment of various cancers. It works by inhibiting DNA replication and RNA synthesis in rapidly dividing cancer cells, leading to effective tumor control.
Product Details
Generic Name: Epirubicin (as Epirubicin Hydrochloride)
Strength: 50 mg
Dosage Form: Injection (Sterile solution for intravenous use)
Route of Administration: Intravenous (IV)
Therapeutic Class: Anthracycline Anticancer Agent
Indications
Epirubicin 50 mg Injection is indicated for the treatment of:
Breast cancer
Gastric cancer
Ovarian cancer
Lung cancer
Soft tissue sarcomas
Lymphomas
Mechanism of Action
Epirubicin intercalates into DNA strands and inhibits topoisomerase II activity, preventing DNA replication and repair. This leads to cancer cell death.
Key Benefits
Broad-spectrum antitumor activity
Effective in combination chemotherapy regimens
Better cardiac safety profile compared to doxorubicin (dose-related)
Widely used in standard oncology protocols
Dosage & Administration
Dosage is determined by the oncologist based on body surface area (BSA), cancer type, and patient condition. Administration should be done only under strict medical supervision.
Storage Conditions
Store at 2°C to 8°C (Refrigerated)
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Monitor cardiac function and blood counts regularly
Use with caution in patients with hepatic impairment
Regulatory Status
Prescription Drug (Rx only)
Disclaimer
This information is intended for website and informational purposes only. Epirubicin 50 mg Injection should be used strictly as prescribed by a qualified healthcare professional.